Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics Price : 3.73 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.78 | 3.78 | 3.72 | 3.73 | 23039.00 |
| Sep 10, 2026 | 3.79 | 3.792 | 3.70 | 3.73 | 42992.00 |
| Sep 09, 2026 | 3.795 | 3.865 | 3.75 | 3.75 | 18608.00 |
| Sep 08, 2026 | 3.84 | 3.84 | 3.72 | 3.75 | 22596.00 |
| Sep 04, 2026 | 3.74 | 3.78 | 3.73 | 3.77 | 21953.00 |
| Sep 03, 2026 | 3.84 | 3.84 | 3.742 | 3.76 | 7462.00 |
| Sep 02, 2026 | 3.84 | 3.84 | 3.75 | 3.75 | 17947.00 |
| Sep 01, 2026 | 3.73 | 3.81 | 3.73 | 3.79 | 20827.00 |
| Aug 31, 2026 | 3.71 | 3.815 | 3.71 | 3.76 | 52204.00 |
| Aug 28, 2026 | 3.72 | 3.835 | 3.72 | 3.76 | 29911.00 |
| Aug 27, 2026 | 3.84 | 3.90 | 3.71 | 3.77 | 50112.00 |
| Aug 26, 2026 | 3.86 | 3.995 | 3.854 | 3.86 | 41028.00 |
| Aug 25, 2026 | 3.93 | 3.96 | 3.85 | 3.86 | 33645.00 |
| Aug 24, 2026 | 3.900 | 4.010 | 3.900 | 3.95 | 58032.00 |
| Aug 21, 2026 | 3.980 | 4.05 | 3.91 | 3.91 | 179817.0 |
| Aug 20, 2026 | 3.98 | 4.00 | 3.92 | 3.95 | 55684.00 |
| Aug 19, 2026 | 4.03 | 4.03 | 3.93 | 3.93 | 24001.00 |
| Aug 18, 2026 | 3.85 | 4.34 | 3.83 | 3.98 | 240456.0 |
| Aug 17, 2026 | 3.91 | 3.97 | 3.781 | 3.85 | 23098.00 |
| Aug 14, 2026 | 3.83 | 3.90 | 3.80 | 3.87 | 23708.00 |
| Aug 13, 2026 | 3.77 | 3.88 | 3.77 | 3.83 | 8923.00 |
| Aug 12, 2026 | 3.79 | 3.87 | 3.75 | 3.81 | 33774.00 |
| Aug 11, 2026 | 3.81 | 3.86 | 3.80 | 3.81 | 30362.00 |
| Aug 10, 2026 | 3.81 | 3.89 | 3.81 | 3.86 | 15499.00 |
| Aug 07, 2026 | 3.88 | 3.98 | 3.82 | 3.82 | 9553.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.94 |
| Amgen, Inc. | 377.35 |
| Anika Therapeutics, Inc. | 20.86 |
| BioCryst Pharmaceuticals, Inc. | 8.12 |
| Imunon, Inc. | 1.47 |
Price Related Metrics
| PE Ratio | 2.931 |
| PS Ratio | 0.8649 |
| Price to Book Value | 0.6817 |
| Earnings Yield | 34.12% |
| Market Cap | 20.06M |
| Operating PE Ratio | 5.567 |
| Normalized PE Ratio | 1.593 |